H Urbach1, S Rauer2, I Mader3, S Paus4, J Wagner5, M P Malter6, H Prüss7, J Lewerenz8, J Kassubek8, H Hegen9, M Auer9, F Deisenhammer9, F Ufer10, C G Bien11, A Baumgartner2. 1. Department of Neuroradiology, University Medical Center Freiburg, Breisacher Str. 64, 79106, Freiburg, Germany. horst.urbach@uniklinik-freiburg.de. 2. Department of Neurology, University Medical Center Freiburg, Freiburg, Germany. 3. Department of Neuroradiology, University Medical Center Freiburg, Breisacher Str. 64, 79106, Freiburg, Germany. 4. Department of Neurology, University Medical Center, Bonn, Germany. 5. Department of Epileptology, University Medical Center, Bonn, Germany. 6. Department of Neurology, University of Cologne, Cologne, Germany. 7. Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany. 8. Department of Neurology, Ulm University, Ulm, Germany. 9. Department of Neurology, University Innsbruck, Innsbruck, Austria. 10. Department of Neurology, University Medical Center, Hamburg, Germany. 11. Epilepsy Centre Bethel, Bielefeld-Bethel, Germany.
Abstract
INTRODUCTION: Limbic encephalitis (LE) associated with voltage-gated potassium channel-complex antibodies (VGKC-LE) is frequently non-paraneoplastic and associated with marked improvement following corticosteroid therapy. Mesial temporal lobe abnormalities are present in around 80 % of patients. If associated or preceded by faciobrachial dystonic seizures, basal ganglia signal changes may occur. In some patients, blurring of the supratentorial white matter on T2-weighted images (SWMB) may be seen. The purpose of this study was to evaluate the incidence of SWMB and whether it is specific for VGKC-LE. METHODS: Two experienced neuroradiologists independently evaluated signal abnormalities on FLAIR MRI in 79 patients with LE while unaware on the antibody type. RESULTS: SWMB was independently assessed as present in 10 of 36 (28 %) compared to 2 (5 %) of 43 non-VGKC patients (p = 0.009). It was not related to the presence of LGI1 or CASPR2 proteins of VGKC antibodies. MRI showed increased temporomesial FLAIR signal in 22 (61 %) VGKC compared to 14 (33 %) non-VGKC patients (p = 0.013), and extratemporomesial structures were affected in one VGKC (3 %) compared to 11 (26 %) non-VGKC patients (p = 0.005). CONCLUSION: SWMB is a newly described MRI sign rather specific for VGKC-LE.
INTRODUCTION: Limbic encephalitis (LE) associated with voltage-gated potassium channel-complex antibodies (VGKC-LE) is frequently non-paraneoplastic and associated with marked improvement following corticosteroid therapy. Mesial temporal lobe abnormalities are present in around 80 % of patients. If associated or preceded by faciobrachial dystonic seizures, basal ganglia signal changes may occur. In some patients, blurring of the supratentorial white matter on T2-weighted images (SWMB) may be seen. The purpose of this study was to evaluate the incidence of SWMB and whether it is specific for VGKC-LE. METHODS: Two experienced neuroradiologists independently evaluated signal abnormalities on FLAIR MRI in 79 patients with LE while unaware on the antibody type. RESULTS: SWMB was independently assessed as present in 10 of 36 (28 %) compared to 2 (5 %) of 43 non-VGKC patients (p = 0.009). It was not related to the presence of LGI1 or CASPR2 proteins of VGKC antibodies. MRI showed increased temporomesial FLAIR signal in 22 (61 %) VGKC compared to 14 (33 %) non-VGKC patients (p = 0.013), and extratemporomesial structures were affected in one VGKC (3 %) compared to 11 (26 %) non-VGKC patients (p = 0.005). CONCLUSION: SWMB is a newly described MRI sign rather specific for VGKC-LE.
Entities:
Keywords:
Epilepsy; Limbic encephalitis; MRI; VGKC; White matter
Authors: Frank Boesebeck; Oliver Schwarz; Bernhard Dohmen; Ulrike Graef; Thomas Vestring; Corinna Kramme; Christian G Bien Journal: J Neurol Date: 2013-05-17 Impact factor: 4.849
Authors: Michael P Malter; Christoph Helmstaedter; Horst Urbach; Angela Vincent; Christian G Bien Journal: Ann Neurol Date: 2010-04 Impact factor: 10.422
Authors: Jan Wagner; Juri-Alexander Witt; Christoph Helmstaedter; Michael P Malter; Bernd Weber; Christian E Elger Journal: J Neurol Neurosurg Psychiatry Date: 2014-09-02 Impact factor: 10.154
Authors: Horst Urbach; Bettina M Soeder; Monika Jeub; Thomas Klockgether; Bernhard Meyer; Christian G Bien Journal: Neuroradiology Date: 2006-04-04 Impact factor: 2.804
Authors: Florian Wegner; Florian Wilke; Peter Raab; Said Ben Tayeb; Anna-Lena Boeck; Cathleen Haense; Corinna Trebst; Elke Voss; Christoph Schrader; Frank Logemann; Jörg Ahrens; Andreas Leffler; Rea Rodriguez-Raecke; Reinhard Dengler; Lilli Geworski; Frank M Bengel; Georg Berding; Martin Stangel; Elham Nabavi Journal: BMC Neurol Date: 2014-06-20 Impact factor: 2.474
Authors: Sarosh R Irani; Charlotte J Stagg; Jonathan M Schott; Clive R Rosenthal; Susanne A Schneider; Philippa Pettingill; Rosemary Pettingill; Patrick Waters; Adam Thomas; Natalie L Voets; Manuel J Cardoso; David M Cash; Emily N Manning; Bethan Lang; Shelagh J M Smith; Angela Vincent; Michael R Johnson Journal: Brain Date: 2013-09-06 Impact factor: 13.501
Authors: L Ernst; B David; J Gaubatz; I Domínguez-Narciso; G Lüchters; A J Becker; B Weber; E Hattingen; C E Elger; T Rüber Journal: AJNR Am J Neuroradiol Date: 2019-11-14 Impact factor: 3.825
Authors: Anna R Tröscher; Andrea Klang; Maria French; Lucía Quemada-Garrido; Sibylle Maria Kneissl; Christian G Bien; Ákos Pákozdy; Jan Bauer Journal: Front Immunol Date: 2017-10-18 Impact factor: 7.561
Authors: Cornelius Deuschl; Theodor Rüber; Leon Ernst; Wolfgang P Fendler; Julian Kirchner; Christoph Mönninghoff; Ken Herrmann; Carlos M Quesada; Michael Forsting; Christian E Elger; Lale Umutlu Journal: PLoS One Date: 2020-01-17 Impact factor: 3.240